Advanced search
Start date
Betweenand


Analysis of the proteins Ki-1/57 and PRMT1: identification, mapping and characterization of the interaction with other proteins

Full text
Author(s):
Dario Oliveira dos Passos
Total Authors: 1
Document type: Doctoral Thesis
Press: Campinas, SP.
Institution: Universidade Estadual de Campinas (UNICAMP). Instituto de Biologia
Defense date:
Examining board members:
Jörg Kobarg; Sandro Roberto Valentini; Lucymara Fassarela Agnes Lima; Íscia Teresinha Lopes Cendes; Gonçalo Amarante Guimarães Pereira
Advisor: Jörg Kobarg
Abstract

The protein Ki-1/57 that is found both in the cytoplasm and nucleus is associated with serine/threonine protein kinase activity and gets phosphorylated on serine and threonine residues upon cellular activation. We demonstrated that Ki-1/57 interacts with the Chromatin-Helicase-DNA-binding domain protein 3 (CHD3) and with the adaptor/signaling protein RACK1 in the nucleus. By utilizing the yeast two-hybrid system (YTHS), we were further able to find the protein arginine-methylatranseferase-1 (PRMT1) as another interacting protein. PRMT1 is a member of the family constituted by 9 human enzymes that catalyze methylation reactions on arginine residues. Afterwards, by using PRMT1 as bait in the YTHS we identified both Ki-1/57 and NSAP1 as interacting proteins, along with 13 other proteins. The majority of them present RGG-box clusters in their amino acid sequences, which are known to be targets for arginine methylation. We further found that Ki-1/57 and its putative paralogue CGI-55 have two RGG/RXR-box clusters conserved between them and that they are substrates for arginine-methylation by PRMT1 in vitro. In mapping studies, we observed that all Ki-1/57 protein fragments containing the RGG/RXRbox clusters interact with PRMT1 and are targets for methylation in vitro. Endogenous cellular Ki-1/57 seems to be methylated in vivo and is a target for methylation by PRMT1 in vitro, only when cells have been previously treated with the methylation inhibitor Adox. Treatment of Hela cells with the inhibitor of methylation (Adox) causes the disappearance of the immuno-staining of Ki-1/57 in the cytoplasm and a relative redistribution of the paralogue CGI-55 to the cytosol. It can therefore be speculated that the methylation of these proteins is important for their sub-cellular localization and in consequence for their function. In summary our data suggest that the YTHS is an effective method for the identification of novel cellular PRMT substrates and could be extended for the identification and characterization of novel substrates to the other components of the human PRMT1 family (AU)